BIB
Ultra Nasdaq Biotechnology
Investment Objective
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
Daily Return during Q1 2024
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.15%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
- Distributions Quarterly
Price
as of 3/28/2024- NAV $57.53
- NAV Change $-0.42
- Market Price $57.54
- Market Price Change $-0.55
- Trading Volume (M) 34,738
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.15%
- NAV Calculation Time 4:00 p.m. ET
- Distributions Quarterly
Price
as of 3/28/2024- NAV $57.53
- NAV Change $-0.42
- Market Price $57.54
- Market Price Change $-0.55
- Trading Volume (M) 34,738
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
The expense ratio above has a contractual waiver ending 9/30/24.
Exposures
Index as of 12/29/2023
Holdings
as of 3/28/2024
Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
---|---|---|---|---|---|---|
50.80% | -- | NASDAQ BIO INDEX SWAP BNP | 50,413,059 | -- | 11,380 | -- |
26.82% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 26,610,830 | -- | 6,007 | -- |
23.04% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 22,867,505 | -- | 5,162 | -- |
14.88% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 14,769,520 | -- | 3,334 | -- |
5.99% | AMGN | AMGEN INC | -- | $5,939,444.80 | 20,890 | 2023607 |
5.90% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 5,851,990 | -- | 1,321 | -- |
5.86% | GILD | GILEAD SCIENCES INC | -- | $5,811,508.50 | 79,338 | 2369174 |
5.74% | REGN | REGENERON PHARMACEUTICALS | -- | $5,698,903.29 | 5,921 | 2730190 |
5.73% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $5,683,263.96 | 13,596 | 2931034 |
4.65% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 4,616,029 | -- | 1,042 | -- |
3.05% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 3,025,670 | -- | 683 | -- |
3.00% | MRNA | MODERNA INC | -- | $2,973,130.56 | 27,901 | BGSXTS3 |
2.90% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,880,865.50 | 42,522 | 2989044 |
2.31% | BIIB | BIOGEN INC | -- | $2,288,912.45 | 10,615 | 2455965 |
1.61% | ILMN | ILLUMINA INC | -- | $1,593,323.96 | 11,603 | 2613990 |
1.39% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,374,491.65 | 9,197 | B00FWN1 |
1.21% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $1,203,283.18 | 13,777 | 2437071 |
1.04% | VTRS | VIATRIS INC | -- | $1,035,436.80 | 86,720 | BMWS3X9 |
1.01% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $1,002,264.64 | 7,267 | 2623911 |
1.00% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $990,639.03 | 32,619 | BMVP7Y0 |
0.98% | SNY | SANOFI-ADR | -- | $972,145.80 | 20,003 | 2964557 |
0.94% | INCY | INCYTE CORP | -- | $934,080.12 | 16,396 | 2471950 |
0.91% | MEDP | MEDPACE HOLDINGS INC | -- | $907,720.90 | 2,246 | BDCBC61 |
0.90% | ARGX | ARGENX SE - ADR | -- | $894,925.56 | 2,273 | BDVLM39 |
0.89% | SRPT | SAREPTA THERAPEUTICS INC | -- | $887,318.84 | 6,854 | B8DPDT7 |
0.80% | UTHR | UNITED THERAPEUTICS CORP | -- | $789,547.64 | 3,437 | 2430412 |
0.66% | BNTX | BIONTECH SE-ADR | -- | $652,299.75 | 7,071 | BK6H543 |
0.64% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $633,855.81 | 4,193 | BV9G6B8 |
0.63% | ROIV | ROIVANT SCIENCES LTD | -- | $620,236.84 | 58,846 | BMW4NZ9 |
0.55% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $548,151.84 | 4,552 | B4Q5ZN4 |
0.54% | PCVX | VAXCYTE INC | -- | $540,741.96 | 7,916 | BKPVGH6 |
0.53% | CYTK | CYTOKINETICS INC | -- | $527,297.31 | 7,521 | BBBSBJ5 |
0.53% | EXEL | EXELIXIS INC | -- | $525,405.93 | 22,141 | 2576941 |
0.52% | APLS | APELLIS PHARMACEUTICALS INC | -- | $517,616.68 | 8,806 | BYTQ6X1 |
0.49% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $489,244.00 | 7,070 | BHCB0P4 |
0.48% | BGNE | BEIGENE LTD-ADR | -- | $472,923.36 | 3,024 | BYYWPW6 |
0.46% | IONS | IONIS PHARMACEUTICALS INC | -- | $461,417.40 | 10,644 | BDJ0LS6 |
0.43% | BPMC | BLUEPRINT MEDICINES CORP | -- | $424,213.92 | 4,472 | BWY52P3 |
0.40% | CRSP | CRISPR THERAPEUTICS AG | -- | $399,553.92 | 5,862 | BDHF4K6 |
0.40% | BBIO | BRIDGEBIO PHARMA INC | -- | $397,012.80 | 12,840 | BK1KWG8 |
0.39% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $388,009.12 | 1,453 | BD59BS7 |
0.39% | RVMD | REVOLUTION MEDICINES INC | -- | $387,630.21 | 12,027 | BL71K91 |
0.38% | HALO | HALOZYME THERAPEUTICS INC | -- | $376,737.48 | 9,261 | 2975098 |
0.37% | KRYS | KRYSTAL BIOTECH INC | -- | $367,603.38 | 2,066 | BD6JX35 |
0.35% | IMVT | IMMUNOVANT INC | -- | $342,809.10 | 10,610 | BJRFSB7 |
0.33% | ALKS | ALKERMES PLC | -- | $330,254.00 | 12,200 | B3P6D26 |
0.33% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $326,387.71 | 5,819 | BMX9K07 |
0.32% | NUVL | NUVALENT INC-A | -- | $321,535.38 | 4,282 | BMVBZD3 |
0.30% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $302,268.72 | 20,396 | BF0DMK7 |
0.30% | INSM | INSMED INC | -- | $294,170.59 | 10,843 | 2614487 |
0.28% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $280,746.97 | 6,013 | BJ62Z18 |
0.28% | AXSM | AXSOME THERAPEUTICS INC | -- | $276,028.20 | 3,459 | BYZR4X4 |
0.27% | ACLX | ARCELLX INC | -- | $268,115.25 | 3,855 | BPCJ1Q2 |
0.27% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $265,197.36 | 5,388 | BGMGM89 |
0.26% | IBRX | IMMUNITYBIO INC | -- | $261,830.46 | 48,758 | BNSP0B8 |
0.26% | FTRE | FORTREA HOLDINGS INC | -- | $260,267.76 | 6,484 | BRXYZ57 |
0.26% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $258,772.80 | 9,048 | BYQBFJ8 |
0.26% | FOLD | AMICUS THERAPEUTICS INC | -- | $254,094.60 | 21,570 | B19FQ48 |
0.24% | IDYA | IDEAYA BIOSCIENCES INC | -- | $238,882.72 | 5,444 | BK0VHF6 |
0.24% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $237,935.23 | 5,083 | BDD19F8 |
0.24% | XENE | XENON PHARMACEUTICALS INC | -- | $237,119.40 | 5,508 | BRJ3GY4 |
0.22% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $222,490.17 | 12,033 | 2713317 |
0.21% | SMMT | SUMMIT THERAPEUTICS INC | -- | $212,137.74 | 51,241 | BMTVQS7 |
0.21% | DNLI | DENALI THERAPEUTICS INC | -- | $208,524.24 | 10,162 | BD2B4V0 |
0.21% | ARVN | ARVINAS INC | -- | $205,244.16 | 4,972 | BDZ30Q0 |
0.20% | BEAM | BEAM THERAPEUTICS INC | -- | $197,017.52 | 5,963 | BK6L288 |
0.19% | NTLA | INTELLIA THERAPEUTICS INC | -- | $193,065.18 | 7,018 | BYZM6C2 |
0.19% | MRUS | MERUS NV | -- | $190,341.81 | 4,227 | BZBY005 |
0.19% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $190,262.03 | 4,391 | BF2YWG4 |
0.19% | ALPN | ALPINE IMMUNE SCIENCES INC | -- | $189,717.04 | 4,786 | BYX38M1 |
0.18% | VCEL | VERICEL CORP | -- | $183,422.52 | 3,526 | BSBMN89 |
0.18% | GH | GUARDANT HEALTH INC | -- | $183,359.44 | 8,888 | BFXC911 |
0.18% | APGE | APOGEE THERAPEUTICS INC | -- | $180,411.75 | 2,715 | BM9HHL5 |
0.18% | KYMR | KYMERA THERAPEUTICS INC | -- | $179,412.60 | 4,463 | BMPRZV5 |
0.18% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $178,046.46 | 6,609 | BDFKQ07 |
0.18% | KROS | KEROS THERAPEUTICS INC | -- | $173,973.60 | 2,628 | BM7V485 |
0.17% | DYN | DYNE THERAPEUTICS INC | -- | $168,153.97 | 5,923 | BN15WD1 |
0.17% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $165,372.39 | 16,587 | BM9FJ13 |
0.17% | VERA | VERA THERAPEUTICS INC | -- | $165,322.08 | 3,834 | BL55460 |
0.16% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $163,670.00 | 2,518 | BLCD809 |
0.16% | PTCT | PTC THERAPEUTICS INC | -- | $162,729.46 | 5,594 | B17VCN9 |
0.16% | SANA | SANA BIOTECHNOLOGY INC | -- | $160,980.00 | 16,098 | BMFJJ97 |
0.16% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $154,211.92 | 3,512 | BNFWZS4 |
0.15% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $152,410.16 | 3,556 | BQS9486 |
0.15% | RNA | AVIDITY BIOSCIENCES INC | -- | $148,577.44 | 5,822 | BMWHPY1 |
0.15% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $147,679.00 | 6,205 | BN7Q7R7 |
0.15% | TWST | TWIST BIOSCIENCE CORP | -- | $144,856.82 | 4,222 | BGKG6G7 |
0.14% | MYGN | MYRIAD GENETICS INC | -- | $139,923.16 | 6,563 | 2614153 |
0.14% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $139,189.10 | 4,145 | BKSGZN7 |
0.14% | JANX | JANUX THERAPEUTICS INC | -- | $139,154.40 | 3,696 | BMFX8Y7 |
0.14% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $136,303.56 | 3,996 | B72ZBG4 |
0.13% | GERN | GERON CORP | -- | $131,587.50 | 39,875 | 2370381 |
0.13% | MORF | MORPHIC HOLDING INC | -- | $128,620.80 | 3,654 | BK8M4J4 |
0.13% | ARDX | ARDELYX INC | -- | $124,041.60 | 16,992 | BN89V40 |
0.12% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $124,013.76 | 6,799 | BKY5JZ8 |
0.12% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $123,097.15 | 4,255 | BDCBCD8 |
0.12% | NVCR | NOVOCURE LTD | -- | $122,226.60 | 7,820 | BYSS4X4 |
0.12% | VCYT | VERACYTE INC | -- | $121,481.12 | 5,482 | BFTWZY0 |
0.12% | INBX | INHIBRX INC | -- | $120,996.56 | 3,461 | BK1MBC3 |
0.12% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $119,971.72 | 4,103 | BCBVTX1 |
0.12% | KURA | KURA ONCOLOGY INC | -- | $118,594.80 | 5,560 | BYZD465 |
0.12% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $118,366.58 | 9,538 | BRJZSK0 |
0.12% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $115,811.10 | 3,635 | BKLXFX5 |
0.11% | FUSN | FUSION PHARMACEUTICALS INC | -- | $112,718.84 | 5,287 | BJK0NH0 |
0.11% | AVDL | AVADEL PHARMACEUTICALS-ADR | -- | $110,680.17 | 6,553 | BDTZ028 |
0.11% | ADMA | ADMA BIOLOGICS INC | -- | $109,989.00 | 16,665 | B9NSBM2 |
0.11% | IRON | DISC MEDICINE INC | -- | $109,702.12 | 1,762 | BMGJZJ8 |
0.11% | ANIP | ANI PHARMACEUTICALS INC | -- | $106,321.94 | 1,538 | BCDWBX6 |
0.11% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $105,414.12 | 6,381 | BLB0YH0 |
0.10% | AKRO | AKERO THERAPEUTICS INC | -- | $103,843.86 | 4,111 | BK7Y2V9 |
0.10% | VIR | VIR BIOTECHNOLOGY INC | -- | $99,881.80 | 9,860 | BK4PZ38 |
0.10% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $99,564.01 | 11,431 | B3MZ6K5 |
0.10% | PCRX | PACIRA BIOSCIENCES INC | -- | $99,231.12 | 3,396 | B3X26D8 |
0.10% | XNCR | XENCOR INC | -- | $98,766.19 | 4,463 | BGCYWN8 |
0.10% | PRTA | PROTHENA CORP PLC | -- | $97,172.71 | 3,923 | B91XRN2 |
0.10% | ABCL | ABCELLERA BIOLOGICS INC | -- | $96,851.40 | 21,380 | BL53SR3 |
0.10% | LGND | LIGAND PHARMACEUTICALS | -- | $94,518.30 | 1,293 | 2501578 |
0.09% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $93,559.68 | 5,268 | BFZQ0L8 |
0.09% | DCPH | DECIPHERA PHARMACEUTICALS IN | -- | $92,807.00 | 5,900 | BZ1LFB2 |
0.09% | GMAB | GENMAB A/S -SP ADR | -- | $91,584.42 | 3,062 | BBC9WC7 |
0.09% | TARS | TARSUS PHARMACEUTICALS INC | -- | $90,838.65 | 2,499 | BMH5RL1 |
0.09% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $90,605.88 | 2,334 | BX7RSN3 |
0.09% | MNKD | MANNKIND CORP | -- | $89,453.91 | 19,747 | BF081J4 |
0.09% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $85,508.48 | 3,404 | BJDX8Y8 |
0.08% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $83,760.87 | 9,661 | BMCWKZ2 |
0.08% | SAGE | SAGE THERAPEUTICS INC | -- | $82,268.60 | 4,390 | BP4GNK9 |
0.08% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $81,668.32 | 5,182 | BMQ5T49 |
0.08% | VERV | VERVE THERAPEUTICS INC | -- | $81,087.68 | 6,106 | BNKGXX2 |
0.08% | VRNA | VERONA PHARMA PLC - ADR | -- | $79,838.58 | 4,962 | BYWPZK5 |
0.08% | RLAY | RELAY THERAPEUTICS INC | -- | $79,505.70 | 9,579 | BN2R582 |
0.08% | ETNB | 89BIO INC | -- | $79,221.84 | 6,806 | BK1K484 |
0.08% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $76,474.32 | 15,054 | 2100362 |
0.07% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $73,709.22 | 3,566 | BMGS7L1 |
0.07% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $73,376.25 | 19,567 | B4N8MH9 |
0.07% | OCUL | OCULAR THERAPEUTIX INC | -- | $73,245.90 | 8,049 | BNZB1X8 |
0.07% | SPRY | ARS PHARMACEUTICALS INC | -- | $71,642.20 | 7,010 | BMCR7V2 |
0.07% | INVA | INNOVIVA INC | -- | $70,363.08 | 4,617 | BDDXF67 |
0.07% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $70,063.70 | 7,070 | BKX9VD3 |
0.07% | RGNX | REGENXBIO INC | -- | $68,372.15 | 3,245 | BZ0G875 |
0.07% | ORIC | ORIC PHARMACEUTICALS INC | -- | $67,636.25 | 4,919 | BKVDFF7 |
0.07% | MGNX | MACROGENICS INC | -- | $66,681.60 | 4,530 | BFDV8K0 |
0.07% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $65,919.04 | 1,952 | BKC9SX3 |
0.07% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $65,573.64 | 10,278 | BFMLGR4 |
0.07% | PLRX | PLIANT THERAPEUTICS INC | -- | $65,545.10 | 4,399 | BMDWW66 |
0.07% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $64,889.40 | 2,606 | BKDQKM6 |
0.06% | PRME | PRIME MEDICINE INC | -- | $59,570.00 | 8,510 | BPBJFM7 |
0.06% | GRFS | GRIFOLS SA-ADR | -- | $59,505.44 | 8,908 | B8K7T65 |
0.06% | TNGX | TANGO THERAPEUTICS INC | -- | $59,137.12 | 7,448 | BP2P6L0 |
0.06% | EOLS | EVOLUS INC | -- | $58,422.00 | 4,173 | BDRJH21 |
0.06% | ZLAB | ZAI LAB LTD-ADR | -- | $57,944.34 | 3,617 | BD9GVY0 |
0.06% | KNSA | KINIKSA PHARMACEUTICALS-A | -- | $57,591.87 | 2,919 | BD0MGM0 |
0.06% | WVE | WAVE LIFE SCIENCES LTD | -- | $54,987.04 | 8,912 | BYZG9R0 |
0.06% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $54,927.36 | 12,288 | BFZNYB7 |
0.05% | ZYME | ZYMEWORKS INC | -- | $53,778.24 | 5,112 | BPCQZY9 |
0.05% | CABA | CABALETTA BIO INC | -- | $53,380.74 | 3,129 | BK5MWR1 |
0.05% | CGEM | CULLINAN ONCOLOGY INC | -- | $53,232.96 | 3,124 | BM90J52 |
0.05% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $52,928.31 | 3,009 | BMFD115 |
0.05% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $52,905.60 | 10,560 | BFWLC09 |
0.05% | NRIX | NURIX THERAPEUTICS INC | -- | $52,479.00 | 3,570 | BMVLGP2 |
0.05% | YMAB | Y-MABS THERAPEUTICS INC | -- | $51,983.22 | 3,197 | BG31GH0 |
0.05% | COGT | COGENT BIOSCIENCES INC | -- | $50,991.36 | 7,588 | BLR6XK8 |
0.05% | CVAC | CUREVAC NV | -- | $49,543.53 | 16,351 | BN4RD42 |
0.05% | SVRA | SAVARA INC | -- | $49,217.34 | 9,883 | BYXGN81 |
0.05% | NVAX | NOVAVAX INC | -- | $48,851.60 | 10,220 | BJDQXG4 |
0.05% | SLRN | ACELYRIN INC | -- | $47,979.00 | 7,108 | BQPF874 |
0.05% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $46,522.10 | 4,117 | BLB0YQ9 |
0.05% | GLPG | GALAPAGOS NV-SPON ADR | -- | $46,400.20 | 1,441 | B292NQ7 |
0.05% | OABI | OMNIAB INC | -- | $46,004.96 | 8,488 | BN13S71 |
0.05% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $45,540.36 | 4,023 | BMZ4LN0 |
0.04% | SIGA | SIGA TECHNOLOGIES INC | -- | $44,434.96 | 5,191 | 2107437 |
0.04% | CSTL | CASTLE BIOSCIENCES INC | -- | $44,410.75 | 2,005 | BKLCWZ3 |
0.04% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $44,402.22 | 4,181 | BJLKVS6 |
0.04% | EDIT | EDITAS MEDICINE INC | -- | $44,334.50 | 5,975 | BZ8FPH3 |
0.04% | ANAB | ANAPTYSBIO INC | -- | $43,711.32 | 1,941 | BDRW1L7 |
0.04% | TRML | TOURMALINE BIO INC | -- | $42,868.80 | 1,872 | BQ80NC6 |
0.04% | TVTX | TRAVERE THERAPEUTICS INC | -- | $42,844.47 | 5,557 | BLFGJD5 |
0.04% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $42,768.00 | 17,820 | BWFZX59 |
0.04% | FULC | FULCRUM THERAPEUTICS INC | -- | $42,697.12 | 4,523 | BJDX8Z9 |
0.04% | ALEC | ALECTOR INC | -- | $42,091.84 | 6,992 | BJ4LDC4 |
0.04% | LYEL | LYELL IMMUNOPHARMA INC | -- | $41,377.65 | 18,555 | BN6MB18 |
0.04% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $40,563.70 | 3,638 | BLN7XQ1 |
0.04% | TSHA | TAYSHA GENE THERAPIES INC | -- | $39,184.11 | 13,653 | BNC1BX1 |
0.04% | BMEA | BIOMEA FUSION INC | -- | $38,974.65 | 2,607 | BNKF6N0 |
0.04% | PETQ | PETIQ INC | -- | $38,972.96 | 2,132 | BDH65C8 |
0.04% | MLYS | MINERALYS THERAPEUTICS INC | -- | $38,755.82 | 3,002 | BP9N0G0 |
0.04% | HCM | HUTCHMED CHINA-ADR | -- | $38,052.00 | 2,265 | BYXV9H7 |
0.04% | VYGR | VOYAGER THERAPEUTICS INC | -- | $36,914.15 | 3,965 | BY7RB53 |
0.04% | REPL | REPLIMUNE GROUP INC | -- | $36,626.11 | 4,483 | BDDVW37 |
0.04% | MRNS | MARINUS PHARMACEUTICALS INC | -- | $36,024.40 | 3,985 | BM8MVZ3 |
0.04% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $36,006.96 | 3,036 | BD06CS0 |
0.04% | ITOS | ITEOS THERAPEUTICS INC | -- | $35,641.32 | 2,613 | BMWXFT4 |
0.03% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $34,009.95 | 10,595 | BJ5FZ74 |
0.03% | HROW | HARROW INC | -- | $33,921.72 | 2,564 | BHNDW86 |
0.03% | URGN | UROGEN PHARMA LTD | -- | $33,810.00 | 2,254 | BZ7PJQ1 |
0.03% | CRBU | CARIBOU BIOSCIENCES INC | -- | $33,194.12 | 6,458 | BNYJR68 |
0.03% | TBPH | THERAVANCE BIOPHARMA INC | -- | $32,623.89 | 3,637 | BMNDK09 |
0.03% | RVNC | REVANCE THERAPEUTICS INC | -- | $31,694.64 | 6,442 | BJFSR99 |
0.03% | MXCT | MAXCYTE INC | -- | $31,693.16 | 7,564 | BKMQF66 |
0.03% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $31,594.68 | 12,246 | BZ0QMB7 |
0.03% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $30,519.64 | 5,996 | BYTYP72 |
0.03% | TERN | TERNS PHARMACEUTICALS INC | -- | $29,598.72 | 4,512 | BMDJ0C9 |
0.03% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $28,189.08 | 4,644 | BFYQFJ2 |
0.03% | THRD | THIRD HARMONIC BIO INC | -- | $27,829.12 | 2,948 | BNNPQY8 |
0.03% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $26,856.90 | 9,135 | BNG1NK8 |
0.03% | PGEN | PRECIGEN INC | -- | $26,356.65 | 18,177 | BKM5C84 |
0.03% | AMRN | AMARIN CORP PLC -ADR | -- | $25,099.18 | 28,176 | 2301938 |
0.03% | AVIR | ATEA PHARMACEUTICALS INC | -- | $24,829.84 | 6,146 | BLN9Z50 |
0.02% | ATAI | ATAI LIFE SCIENCES NV | -- | $23,882.31 | 12,123 | BN6M8F1 |
0.02% | VTYX | VENTYX BIOSCIENCES INC | -- | $23,798.50 | 4,327 | BMG99Y1 |
0.02% | HUMA | HUMACYTE INC | -- | $23,524.04 | 7,564 | BMYTJP4 |
0.02% | ERAS | ERASCA INC | -- | $22,727.98 | 11,033 | BNLYBF3 |
0.02% | RAPT | RAPT THERAPEUTICS INC | -- | $22,548.78 | 2,511 | BK5T6R0 |
0.02% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $22,292.27 | 10,087 | BLR7H87 |
0.02% | ACIU | AC IMMUNE SA | -- | $21,356.40 | 7,215 | BZC0D70 |
0.02% | EXAI | EXSCIENTIA PLC | -- | $20,151.56 | 3,523 | BP48134 |
0.02% | CHRS | COHERUS BIOSCIENCES INC | -- | $19,435.48 | 8,132 | BRK0149 |
0.02% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $19,201.05 | 1,485 | BL95N25 |
0.02% | QURE | UNIQURE NV | -- | $18,168.80 | 3,494 | BJFSR88 |
0.02% | BLUE | BLUEBIRD BIO INC | -- | $17,793.28 | 13,901 | BBFL7S1 |
0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $17,266.11 | 4,201 | B12W3P6 |
0.02% | OVID | OVID THERAPEUTICS INC | -- | $15,741.05 | 5,161 | BYPFK63 |
0.01% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $14,055.16 | 4,949 | BPCK358 |
0.01% | ME | 23ANDME HOLDING CO -CLASS A | -- | $12,254.62 | 23,035 | BM9CKX3 |
0.01% | -- | ACHILLION PHARMACEUTICALS INC - CVR | -- | $11,641.22 | 25,307 | -- |
0.01% | ACRS | ACLARIS THERAPEUTICS INC | -- | $6,423.20 | 5,180 | BYV2W40 |
-- | RPHM | RENEO PHARMACEUTICALS INC | -- | $4,038.78 | 2,433 | BMHR7T5 |
-- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
-- | -- | TREASURY BILL | -- | $14,724,867.15 | 15,000,000 | BRYQ9Y9 |
-- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $13,919,365.78 | 13,919,366 | -- |
Index
as of 12/29/2023
- Total Number of Companies225
- Price/Earnings Ratio--
- Price/Book Ratio4.289
- Dividend Yield ( % )0.79
- Avg. Index Market Capitalization$6.63 billion
About the Index
The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.
Distributions
For
- 2024
- 2023
- 2022
Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
---|